Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal CancerAntonio Avallone, Alfredo Budillon, Carmela Romano et al.|JAMA Network Open|2021Cited by 34
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with <i>RAS</i> -mutated metastatic colorectal cancer: the REVOLUTION study protocolAntonio Avallone, Alfredo Budillon, Maria Carmela Piccirillo et al.|Therapeutic Advances in Medical Oncology|2020Cited by 17
Update survival analysis from a multicenter, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC).Antonio Avallone, Maria Carmela Piccirillo, Guglielmo Nasti et al.|Journal of Clinical Oncology|2018Cited by 1